Immunic, Inc. Common Stock (IMUX)

Typically moves ±6.42% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-10 ESTIMATED

Immunic, Inc. Common Stock (IMUX) has a 19-report earnings history dating back to Aug 06, 2021. Its average absolute post-earnings move is ±6.42%, and 52.6% of those reactions were positive. Its largest post-earnings gain was +22.7% (Aug 04, 2022) and its largest decline was -9.32% (Feb 24, 2022). The next earnings report is predicted for 2026-11-10 (estimated).

Earnings reactions

How IMUX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.42%

Positive %

52.6%

Negative %

47.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☀ PRE	+9.27%	open_in_new
May 13, 2026	☀ PRE	+9.7%	open_in_new
Feb 26, 2026	☀ PRE	+4.27%	open_in_new
Nov 13, 2025	☀ PRE	-6.37%	open_in_new
Aug 07, 2025	☀ PRE	-7.68%	open_in_new
Nov 07, 2024	☀ PRE	-1.26%	open_in_new
Aug 08, 2024	☀ PRE	+13.79%	open_in_new
May 08, 2024	☀ PRE	-1.44%	open_in_new
Feb 22, 2024	☀ PRE	-8.91%	open_in_new
Nov 14, 2023	☀ PRE	+2.07%	open_in_new
Aug 03, 2023	☀ PRE	-0.69%	open_in_new
May 11, 2023	☀ PRE	+1.11%	open_in_new
Feb 23, 2023	☀ PRE	+5.08%	open_in_new
Nov 03, 2022	☀ PRE	-6.12%	open_in_new
Aug 04, 2022	☀ PRE	+22.7%	open_in_new
May 10, 2022	☀ PRE	+5.88%	open_in_new
Feb 24, 2022	☀ PRE	-9.32%	open_in_new
Nov 04, 2021	☽ POST	-0.68%	open_in_new
Aug 06, 2021	☽ POST	+5.57%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.42%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 11 →

Funds holding

$6979221

Total value held

Buying

11 added · 0 reduced

Ubs Group Ag

$2701369 NEW BUY

Blackrock, Inc.

$2040998 NEW BUY

Jefferies Financial Group Inc.

$1304913 NEW BUY

Northern Trust Corp

$472166 NEW BUY

Morgan Stanley

$365007 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

7 chevron_right

description 3

3 chevron_right

description SCHEDULE 13G

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
S-8	20260812	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
3	20260810	open_in_new SEC.gov
4	20260810	open_in_new SEC.gov
SCHEDULE 13G/A	20260806	open_in_new SEC.gov

Frequently asked about IMUX earnings

When does Immunic, Inc. Common Stock report earnings next? expand_more

Immunic, Inc. Common Stock (IMUX)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does IMUX stock move after earnings? expand_more

Over 19 reports, IMUX has moved an average of ±6.42% the session after earnings, closing higher 52.6% of the time.

What was IMUX's biggest post-earnings move? expand_more

IMUX's largest post-earnings gain on record was +22.7% on Aug 04, 2022, and its largest decline was -9.32% on Feb 24, 2022.

Where can I find Immunic, Inc. Common Stock's SEC filings? expand_more

All of Immunic, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.